MBB Public Markets I LLC Makes New Investment in DaVita Inc. (NYSE:DVA)

MBB Public Markets I LLC acquired a new position in DaVita Inc. (NYSE:DVA) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 4,200 shares of the company’s stock, valued at approximately $582,000.

Several other hedge funds have also added to or reduced their stakes in DVA. Franklin Resources Inc. raised its position in shares of DaVita by 42.0% in the fourth quarter. Franklin Resources Inc. now owns 7,866 shares of the company’s stock valued at $824,000 after purchasing an additional 2,325 shares during the period. Advisory Services Network LLC bought a new stake in DaVita during the 4th quarter valued at $385,000. Treasurer of the State of North Carolina raised its holdings in DaVita by 1.0% during the 4th quarter. Treasurer of the State of North Carolina now owns 24,737 shares of the company’s stock valued at $2,591,000 after buying an additional 234 shares during the last quarter. TFO Wealth Partners LLC raised its holdings in DaVita by 56,133.3% in the 4th quarter. TFO Wealth Partners LLC now owns 1,687 shares of the company’s stock worth $177,000 after purchasing an additional 1,684 shares in the last quarter. Finally, California State Teachers Retirement System raised its holdings in DaVita by 4.2% in the 4th quarter. California State Teachers Retirement System now owns 87,217 shares of the company’s stock worth $9,137,000 after purchasing an additional 3,543 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of NYSE DVA opened at $162.75 on Wednesday. The firm’s 50-day moving average price is $151.04 and its 200-day moving average price is $142.52. DaVita Inc. has a 52-week low of $71.51 and a 52-week high of $166.04. The company has a quick ratio of 1.12, a current ratio of 1.16 and a debt-to-equity ratio of 9.94. The company has a market cap of $13.65 billion, a PE ratio of 18.49, a PEG ratio of 0.93 and a beta of 0.87.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.47 by $0.12. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The firm had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.15 billion. During the same quarter in the prior year, the business earned $2.08 EPS. The business’s quarterly revenue was up 6.2% on a year-over-year basis. As a group, analysts anticipate that DaVita Inc. will post 9.99 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the sale, the chief executive officer now owns 837,835 shares in the company, valued at $138,284,666.75. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the sale, the chief executive officer now owns 837,835 shares in the company, valued at $138,284,666.75. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Joel Ackerman sold 64,029 shares of the firm’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the completion of the transaction, the chief financial officer now directly owns 111,481 shares of the company’s stock, valued at $17,286,243.86. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 173,482 shares of company stock worth $27,387,069. Company insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on DVA. Truist Financial upped their price objective on shares of DaVita from $150.00 to $165.00 and gave the stock a “hold” rating in a report on Tuesday, August 20th. TD Cowen increased their price objective on shares of DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Bank of America increased their price objective on shares of DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research report on Wednesday, August 7th. UBS Group increased their price objective on shares of DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Finally, StockNews.com downgraded shares of DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, DaVita presently has an average rating of “Hold” and an average price target of $157.00.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.